Reviewing Dolby Laboratories (NYSE:DLB) and Amesite (NASDAQ:AMST)

Dolby Laboratories (NYSE:DLB) and Amesite (NASDAQ:AMST) are both technology companies, but which is the superior investment? We will contrast the two companies based on the strength of their analyst recommendations, risk, valuation, earnings, profitability, institutional ownership and dividends.

Volatility & Risk

Dolby Laboratories has a beta of 0.79, meaning that its stock price is 21% less volatile than the S&P 500. Comparatively, Amesite has a beta of 1.12, meaning that its stock price is 12% more volatile than the S&P 500.

Valuation and Earnings

This table compares Dolby Laboratories and Amesite”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Dolby Laboratories	$1.35 billion	4.47	$255.02 million	$2.35	27.39
Amesite	$370,000.00	8.87	-$3.10 million	($0.63)	-0.80

Dolby Laboratories has higher revenue and earnings than Amesite. Amesite is trading at a lower price-to-earnings ratio than Dolby Laboratories, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Dolby Laboratories and Amesite’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Dolby Laboratories	16.70%	11.08%	9.04%
Amesite	-850.55%	-162.26%	-135.85%

Institutional and Insider Ownership

58.6% of Dolby Laboratories shares are held by institutional investors. Comparatively, 3.6% of Amesite shares are held by institutional investors. 37.9% of Dolby Laboratories shares are held by insiders. Comparatively, 33.2% of Amesite shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Analyst Recommendations

This is a breakdown of recent ratings and recommmendations for Dolby Laboratories and Amesite, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Dolby Laboratories	1	1	2	0	2.25
Amesite	1	0	0	0	1.00

Dolby Laboratories currently has a consensus target price of $87.50, indicating a potential upside of 35.96%. Given Dolby Laboratories’ stronger consensus rating and higher possible upside, analysts plainly believe Dolby Laboratories is more favorable than Amesite.

Summary

Dolby Laboratories beats Amesite on 12 of the 14 factors compared between the two stocks.

About Dolby Laboratories

Dolby Laboratories, Inc. develops audio and imaging technologies used in entertainment and consumer electronics. Its offerings include Dolby Atmos immersive audio, Dolby Vision high-dynamic-range imaging, and technologies for encoding, delivering and reproducing sound and video. The company licenses its technologies to manufacturers and content businesses across areas such as film, television, streaming, gaming and mobile devices. Dolby also supports cinema experiences through technologies and services including Dolby Cinema.

About Amesite

Amesite Inc. (NASDAQ:AMST) is an education technology company that develops artificial intelligence-powered learning and workforce training solutions. Its technology is designed to help organizations create, deliver and manage online educational content through cloud-based platforms. The company’s offerings have included learning management and course-delivery tools for higher education institutions, businesses, government organizations and professional training providers. Amesite has also developed AI-based applications intended to support specialized learning and workforce needs, including tools for content creation, learner engagement and skills development.